Cyanidin-3-O-Glucoside improves the viability of human islet cells treated with amylin or Aβ1-42 in vitro.

PLoS One · 2021 · PMC8494376 · PMID 34614009

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

C3G-treated islets exposed to amylin (1.08±0.46, n = 5) or Aβ 1–42 (1.14±0.28, n = 5) showed a decreasing trend in the levels of ROS compared to islets exposed to amylin or Aβ 1-42 without C3G.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.